EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine

Rosa Perestrelo iD, Catarina Luís iD

Metabolites · 23.06.2025 · 15 (7) · 428

DOI: 10.3390/metabo15070428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 23.06.2025. Verfasst von Rosa Perestrelo und 1 weiteren Autor:innen. Beteiligte Einrichtung: CQM-Centro de Química da Madeira, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia (FCT) with Portuguese Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is a highly heterogeneous disease with distinct molecular subtypes, each exhibiting unique metabolic adaptations that drive tumor progression and therapy resistance. Metabolomics has emerged as a powerful tool for understanding cancer metabolism and identifying clinically relevant biomarkers guiding personalized therapeutic strategies. Advances in analytical techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy have enabled the identification of metabolic alterations associated with BC initiation, progression, and treatment response (dysregulated glycolysis, lipid metabolism, amino acid utilization, and redox homeostasis). This review aims to provide a comprehensive overview of the role of metabolomics in BC research, focusing on its applications in identifying metabolic biomarkers for early diagnosis, prognosis, and treatment response. It underscores how metabolomic profiling can unravel the metabolic adaptations of different BC subtypes, offering insights into tumor biology and mechanisms of therapy resistance. Ultimately, it highlights the promise of metabolomics in driving biomarker-guided diagnostics and the development of metabolically informed, personalized therapeutic strategies in the era of precision medicine.

Schlagwörter

Stichwörter der Autor:innen

biomarker discoverybreast cancermetabolomicspersonalized medicine

Autor:innen und Institutionen

  • CQM-Centro de Química da Madeira, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal.
  • Faculdade de Ciências da Vida, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal.

ORCID-Profile: Rosa Perestrelo, Catarina Luís

Förderung

  • Fundação para a Ciência e a Tecnologia (FCT) with Portuguese Government

Zitieren

APA

Perestrelo, R., & Luís, C. (2025). Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine. Metabolites, 15(7), 428. https://doi.org/10.3390/metabo15070428

Vancouver

Perestrelo R, Luís C. Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine. Metabolites. 2025;15(7):428. doi:10.3390/metabo15070428

BibTeX
@article{Perestrelo2025,
  author = {Perestrelo, Rosa and Luís, Catarina},
  title = {Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {428},
  doi = {10.3390/metabo15070428}
}
Kostenlos starten →